Prenatal diagnosis of Duchenne muscular dystrophy

Prenatal diagnosis of Duchenne muscular dystrophy - Prenatal diagnosis of Duchenne muscular dystrophy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030722

Enrollment

Registered

2018-02-01

Start date

2018-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne muscular dystrophy

Interventions

The carrier can choose an examination for amniocentetis or chorionic villi sampling. The amuniocentetis is performed between 15and 16 weeks of gestation and the chorionic villi is collected between 1

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: pregnant female diagnosed DMD carrier

Exclusion criteria

Exclusion criteria: pregnant female who does not have a diagnosis of DMD carrier

Design outcomes

Primary

Measure	Time frame
The samples are collected from chorionic villi between 11 and 12 weeks of gastation or amnionic cells between 15 and 16 weeks of gestation. If the fetus is male,The genetic testing is perfoemed.	—

Countries

Japan

Contacts

Public ContactYuuko Yokohama

Asahikawa medical university Division of obstetrics and Gynecology

yukoy@asahikawa-med.ac.jp0166-68-2562

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026